Trial · NCT07898904
Incremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases
NCT07898904, Recruiting, First Affiliated Hospital of Fujian Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Incremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases. Trials, record NCT07898904. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898904
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Incremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases
- NCT number
- NCT07898904
- Status
- Recruiting
- Enrollment
- 46 participants, estimated
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Conditions
- Gastroenteropancreatic Neuroendocrine Tumors
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 1. Sensitivity of Delayed ^68^Ga-DOTATATE PET/MR in Detecting Liver Metastases from GEP-NETs Relative to Conventional Imaging | Conventional imaging (MRI or CT) was performed within 3 months of the PET studies. | Using contrast-enhanced MRI or CT as the reference standard, validate the true positive detection rate of delayed \^68\^Ga-DOTATATE PET/MR for liver metastases in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Two experienced readers, blinded to the clinical history but not to the imaging modality, independently assessed the PET/MR and PET/CT images. Disagreements were resolved by consensus. |
| Primary | 2. Lesion Detection Rate of Delayed ^68^Ga-DOTATATE PET/MR Compared to Conventional PET/CT in Patients with GEP-NETs | All PET/CT and PET/MR scans were performed on the same day following a single radiotracer injection. | Using a composite reference standard including conventional imaging (MRI/CT) and consensus reading, compare the number and characteristics of liver metastases detected by delayed PET/MR versus conventional PET/CT. Two accredited readers evaluated the images in separate sessions. Additional lesions identified only on PET/MR were categorized as high-uptake or non-uptake based on \^68\^Ga-DOTATATE avidity. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898904
GET https://conductscience.org/api/trials/v1/NCT07898904/registered